These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 15316798

  • 1. Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control.
    Diener HC, Tfelt-Hansen P, Dahlöf C, Láinez MJ, Sandrini G, Wang SJ, Neto W, Vijapurkar U, Doyle A, Jacobs D, MIGR-003 Study Group.
    J Neurol; 2004 Aug; 251(8):943-50. PubMed ID: 15316798
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Jul; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 5. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.
    Clin Neuropharmacol; 2006 Jul; 29(5):269-75. PubMed ID: 16960472
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 9. Topiramate improves health-related quality of life when used to prevent migraine.
    Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC.
    Headache; 2005 Sep; 45(8):1023-30. PubMed ID: 16109116
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topiramate in migraine prophylaxis.
    D'Amico D, Grazzi L, Usai S, Moschiano F, Bussone G.
    Neurol Sci; 2005 May; 26 Suppl 2():s130-3. PubMed ID: 15926010
    [Abstract] [Full Text] [Related]

  • 12. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.
    Mei D, Capuano A, Vollono C, Evangelista M, Ferraro D, Tonali P, Di Trapani G.
    Neurol Sci; 2004 Dec; 25(5):245-50. PubMed ID: 15624081
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
    Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, Kurland CL, Nye J, Yuen E, Eerdekens M, Ford L.
    Pediatrics; 2009 Mar; 123(3):924-34. PubMed ID: 19255022
    [Abstract] [Full Text] [Related]

  • 16. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial.
    Lakshmi CV, Singhi P, Malhi P, Ray M.
    J Child Neurol; 2007 Jul; 22(7):829-35. PubMed ID: 17715274
    [Abstract] [Full Text] [Related]

  • 19. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
    Brandes JL, Kudrow DB, Rothrock JF, Rupnow MF, Fairclough DL, Greenberg SJ.
    Mayo Clin Proc; 2006 Oct; 81(10):1311-9. PubMed ID: 17036556
    [Abstract] [Full Text] [Related]

  • 20. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.